Please login to the form below

Not currently logged in

Envigo appoints Lizanne Muller as president, EMEA operations

And Craig Boyd joins from Mayne Pharma as chief commercial officer

Lizanne MullerContract research organisation Envigo has appointed Lizanne Muller as president of its EMEA operations.

She brings 18 years’ experience working within a multinational pharmaceutical manufacturing company, with 16 years spent at the Dishman Group serving in a variety of roles of increasing responsibility, including vice president of compliance and governance.

In her new role Muller will be accountable for Envigo’s contract research services and research services models operations across Europe and Asia.

Envigo has also appointed Craig Boyd as chief commercial officer.

He has more than 20 years’ experience in various global pharmaceutical markets and was previously executive vice president of Mayne Pharma’s US specialty brands division.

Prior to this, Craig led the global commercial sales functions at Hospira and Mylan, and spent 10 years as a senior commercial sales and marketing executive at Novartis.

Both will serve on the company’s executive committee and report to CEO Dr Adrian Hardy, who said both would bring great experience and knowledge to the firm.

He added: "Their experience and expertise will help us grow Envigo as we continue to focus on delighting our customers with great products and services. It’s a really exciting time at Envigo right now, with emphasis on enhancing our customers’ experience of working with us and cementing our presence as leaders in the markets we serve.”

28th September 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...